The use of immunotherapy in the first-line treatment of lung cancer
Rizvi, N.A.
Clinical Advances in Hematology and Oncology H&o 15(3): 190-192
2017
ISSN/ISBN: 1543-0790 PMID: 28398273 Document Number: 694755
Document emailed within 1 workday
Related Documents
Bourlon, M.ía.T.; Velázquez, H.E.; Luna-Santiago, R.; Vázquez-Manjarrez, S.; Bourlon, C. 2018: Is this Patient with Metastatic Bladder Cancer a Candidate for Second-Line Immunotherapy Treatment? Oncology 32(2): 64-68Li, P.S. 1993: The future application of adoptive immunotherapy in treatment of lung cancer Zhonghua Nei Ke Za Zhi 32(9): 579-580
1989: Diagnosis and first-line treatment of patients with lung cancer in Italian general hospitals. G.I.V.I.O. (Interdisciplinary Group for Cancer Evaluation) Tumori 75(2): 163-167
Nakamura, Y.; Yamamoto, N. 2009: Second-line treatment and targeted therapy of advanced lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 710-716
Little, A.G.; DeMeester, T.R.; Ferguson, M.K.; Skinner, D.B.; Hoffman, P.C.; Skosey, C.; Blough, R.R.; Golomb, H.M. 1986: Modified stage i (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy Surgery 100(4): 621-628
Moro-Sibilot, D.; Coudurier, M. 2009: Targeted therapies in second line treatment of metastatic non-small cell lung cancer La Revue du Praticien 59(7): 955-956
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Ryo, H.; Toyama, K.; Isobe, K.; Sugino, K.; Sano, G.; Yamada, H.; Hiroi, M.; Hojyo, T.; Kimura, K. 2003: A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 237-242
Bilgi, O.; Karagoz, B.; Alacacioglu, A.; Ozgun, A.; Tuncel, T.; Gokhan-Kandemir, E. 2010: Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 395
Giannakakis, T.; Kakolyris, S.; Theodoropoulos, E.; Kouroussis, C.; Michailakis, E.; Papadouris, S.; Tsitoura, M.; Kalbakis, K.; Souglakos, J.; Agelaki, S.; Vardakis, N.; Georgoulias, V. 2002: A multicenter phase Ii study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer Anticancer Research 22(6b): 3743-3748
Panettiere, F.J.; Constanzi, J.J. 1979: Advances in the chemotherapy and immunotherapy of lung cancer Texas Medicine 75(2): 95-97
Meganem, H.; Socianu, R.-M.; Bouchaab, H.; Mederos, N.; Nguyen-Ngoc, T.; Peters, S.; Dolcan, A. 2019: The new management options for lung cancer in the immunotherapy era Revue Medicale Suisse 15(651): 1032-1037
Hersh, E.M.; Mavligit, G.M.; Gutterman, J.U. 1974: Immunotherapy as related to lung cancer: a review Seminars in Oncology 1(3): 273-278
Wachters, F.M.; Van Der Graaf, W.T.A.; Groen, H.J.M. 2004: Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment Anticancer Research 24(3b): 2079-2083
Watanabe, Y.; Shimizu, J.; Oda, M.; Yoshida, M.; Watanabe, S.; Iwa, T. 1991: Clinical significance of immunotherapy for lung cancer--present and future Nihon Geka Gakkai Zasshi 92(9): 1217-1220
Muto, S.; Suzuki, H. 2018: Recent Advances in Immunotherapy for Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(2): 212-216
Lenzi, M. 1977: Growth curves in radio-chemo-immunotherapy of lung cancer La Radiologia Medica 63(2): 111-120
Fujisawa, T. 1985: Transfer factor immunotherapy as an adjunct to surgery in lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 23(1): 68-73
Lin, J.C.; Cheng, J.Y.; Meng, C.L. 1992: An animal model for colon cancer metastases to the lung and establishment of metastatic cancer cell line Journal of the Formosan Medical Association 91(Suppl 1): S34-S38
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113